Rating History for Summit Therapeutics plc (SMMT) by Bernstein SocGen Group
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/5/2026 | Jeffrey Walch | Maintain | Market Perform (N/A) |
11.90 (N/A) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/5/2026 | Jeffrey Walch | Maintain | Market Perform (N/A) |
11.90 (N/A) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||